APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biochemical Screening Test

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biochemical Screening Test Market Outlook and Growth Opportunities 2026

4 July 2026196 pages

Choose your research edition.

Industry ResearchBiochemical Screening Test Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Biochemical Screening Test Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biochemical Screening Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biochemical Screening Test Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Biochemical Screening Test Market Analysis and Forecast 2026-2032176 pages · $4,950 USD

Market perspective

The global Biochemical Screening Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biochemical Screening Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biochemical Screening Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biochemical Screening Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biochemical Screening Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biochemical Screening Test market include Yourgene Health, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc and BGI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biochemical Screening Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biochemical Screening Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biochemical Screening Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biochemical Screening Test market.

Biochemical Screening Test Segment by Company

Yourgene Health

Illumina Inc

Agilent Technologies Inc

Thermo Fisher Scientific Inc

Hoffmann-La Roche Ltd

Laboratory Corporation of America Holdings

GE Healthcare

PerkinElmer Inc

BGI

Natera Inc

Biochemical Screening Test Segment by Type

Combined First Trimester Screening

Second Trimester Maternal Serum Screening

Biochemical Screening Test Segment by Application

Diagnostic Laboratories

Hospitals

Biochemical Screening Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biochemical Screening Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biochemical Screening Test key companies, revenue, market share, and recent developments.

3. To split the Biochemical Screening Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biochemical Screening Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biochemical Screening Test significant trends, drivers, influence factors in global and regions.

6. To analyze Biochemical Screening Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biochemical Screening Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biochemical Screening Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biochemical Screening Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biochemical Screening Test industry.

Chapter 3: Detailed analysis of Biochemical Screening Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biochemical Screening Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biochemical Screening Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biochemical Screening Test Industry Trends Table 2. Biochemical Screening Test Industry Drivers Table 3. Biochemical Screening Test Industry Opportunities and Challenges Table 4. Biochemical Screening Test Industry Restraints Table 5. Global Biochemical Screening Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biochemical Screening Test Revenue Share by Company (2021-2026) Table 7. Global Biochemical Screening Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biochemical Screening Test Key Company Manufacturing Base & Headquarters Table 9. Global Biochemical Screening Test Company, Product Type & Application Table 10. Global Biochemical Screening Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biochemical Screening Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Combined First Trimester Screening Table 15. Significant Companies of Second Trimester Maternal Serum Screening Table 16. Global Biochemical Screening Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biochemical Screening Test Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biochemical Screening Test Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biochemical Screening Test Sales Value Share by Type (2021-2026) Table 20. Global Biochemical Screening Test Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Diagnostic Laboratories Table 22. Significant Companies of Hospitals Table 23. Global Biochemical Screening Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Biochemical Screening Test Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Biochemical Screening Test Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Biochemical Screening Test Sales Value Share by Application (2021-2026) Table 27. Global Biochemical Screening Test Sales Value Share by Application (2027-2032) Table 28. Global Biochemical Screening Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biochemical Screening Test Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Biochemical Screening Test Sales Value Share by Region (2021-2026) Table 31. Global Biochemical Screening Test Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Biochemical Screening Test Sales Value Share by Region (2027-2032) Table 33. Global Biochemical Screening Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biochemical Screening Test Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Biochemical Screening Test Sales Value Market Share by Country (2021-2026) Table 36. Global Biochemical Screening Test Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Biochemical Screening Test Sales Value Market Share by Country (2027-2032) Table 38. Yourgene Health Company Information Table 39. Yourgene Health Business Overview Table 40. Yourgene Health Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Yourgene Health Biochemical Screening Test Product Portfolio Table 42. Yourgene Health Recent Development Table 43. Illumina Inc Company Information Table 44. Illumina Inc Business Overview Table 45. Illumina Inc Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Illumina Inc Biochemical Screening Test Product Portfolio Table 47. Illumina Inc Recent Development Table 48. Agilent Technologies Inc Company Information Table 49. Agilent Technologies Inc Business Overview Table 50. Agilent Technologies Inc Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Agilent Technologies Inc Biochemical Screening Test Product Portfolio Table 52. Agilent Technologies Inc Recent Development Table 53. Thermo Fisher Scientific Inc Company Information Table 54. Thermo Fisher Scientific Inc Business Overview Table 55. Thermo Fisher Scientific Inc Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Thermo Fisher Scientific Inc Biochemical Screening Test Product Portfolio Table 57. Thermo Fisher Scientific Inc Recent Development Table 58. Hoffmann-La Roche Ltd Company Information Table 59. Hoffmann-La Roche Ltd Business Overview Table 60. Hoffmann-La Roche Ltd Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Hoffmann-La Roche Ltd Biochemical Screening Test Product Portfolio Table 62. Hoffmann-La Roche Ltd Recent Development Table 63. Laboratory Corporation of America Holdings Company Information Table 64. Laboratory Corporation of America Holdings Business Overview Table 65. Laboratory Corporation of America Holdings Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Laboratory Corporation of America Holdings Biochemical Screening Test Product Portfolio Table 67. Laboratory Corporation of America Holdings Recent Development Table 68. GE Healthcare Company Information Table 69. GE Healthcare Business Overview Table 70. GE Healthcare Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GE Healthcare Biochemical Screening Test Product Portfolio Table 72. GE Healthcare Recent Development Table 73. PerkinElmer Inc Company Information Table 74. PerkinElmer Inc Business Overview Table 75. PerkinElmer Inc Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. PerkinElmer Inc Biochemical Screening Test Product Portfolio Table 77. PerkinElmer Inc Recent Development Table 78. BGI Company Information Table 79. BGI Business Overview Table 80. BGI Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. BGI Biochemical Screening Test Product Portfolio Table 82. BGI Recent Development Table 83. Natera Inc Company Information Table 84. Natera Inc Business Overview Table 85. Natera Inc Biochemical Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Natera Inc Biochemical Screening Test Product Portfolio Table 87. Natera Inc Recent Development Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Biochemical Screening Test Product Image Figure 2. Global Biochemical Screening Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biochemical Screening Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Biochemical Screening Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Combined First Trimester Screening Image Figure 8. Second Trimester Maternal Serum Screening Image Figure 9. Global Biochemical Screening Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biochemical Screening Test Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biochemical Screening Test Sales Value Share by Type (2021-2032) Figure 12. Diagnostic Laboratories Image Figure 13. Hospitals Image Figure 14. Global Biochemical Screening Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Biochemical Screening Test Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Biochemical Screening Test Sales Value Share by Application (2021-2032) Figure 17. Global Biochemical Screening Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Biochemical Screening Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Biochemical Screening Test Sales Value (2021-2032) & (US$ Million) Figure 20. North America Biochemical Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Biochemical Screening Test Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Biochemical Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Biochemical Screening Test Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Biochemical Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Biochemical Screening Test Sales Value (2021-2032) & (US$ Million) Figure 26. South America Biochemical Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Biochemical Screening Test Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Biochemical Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Biochemical Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Combined First Trimester Screening
  • Second Trimester Maternal Serum Screening
Applications
  • Diagnostic Laboratories
  • Hospitals
Companies covered
  • Yourgene Health
  • Illumina Inc
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • Hoffmann-La Roche Ltd
  • Laboratory Corporation of America Holdings
  • GE Healthcare
  • PerkinElmer Inc
  • BGI
  • Natera Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biochemical Screening Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biochemical Screening Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biochemical Screening Test Market Dynamics
  1. 2.1 Biochemical Screening Test Industry Trends
  2. 2.2 Biochemical Screening Test Industry Drivers
  3. 2.3 Biochemical Screening Test Industry Opportunities and Challenges
  4. 2.4 Biochemical Screening Test Industry Restraints
3 Biochemical Screening Test Market by Company
  1. 3.1 Global Biochemical Screening Test Company Revenue Ranking in 2025
  2. 3.2 Global Biochemical Screening Test Revenue by Company (2021-2026)
  3. 3.3 Global Biochemical Screening Test Company Ranking (2024-2026)
  4. 3.4 Global Biochemical Screening Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Biochemical Screening Test Company Product Type and Application
  6. 3.6 Global Biochemical Screening Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biochemical Screening Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biochemical Screening Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biochemical Screening Test Market by Type
  1. 4.1 Biochemical Screening Test Type Introduction
  2. 4.1.1 Combined First Trimester Screening
  3. 4.1.2 Second Trimester Maternal Serum Screening
  4. 4.2 Global Biochemical Screening Test Sales Value by Type
  5. 4.2.1 Global Biochemical Screening Test Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biochemical Screening Test Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biochemical Screening Test Sales Value Share by Type (2021-2032)
5 Biochemical Screening Test Market by Application
  1. 5.1 Biochemical Screening Test Application Introduction
  2. 5.1.1 Diagnostic Laboratories
  3. 5.1.2 Hospitals
  4. 5.2 Global Biochemical Screening Test Sales Value by Application
  5. 5.2.1 Global Biochemical Screening Test Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biochemical Screening Test Sales Value by Application (2021-2032)
  7. 5.2.3 Global Biochemical Screening Test Sales Value Share by Application (2021-2032)
6 Biochemical Screening Test Regional Value Analysis
  1. 6.1 Global Biochemical Screening Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biochemical Screening Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biochemical Screening Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biochemical Screening Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biochemical Screening Test Sales Value (2021-2032)
  7. 6.3.2 North America Biochemical Screening Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biochemical Screening Test Sales Value (2021-2032)
  10. 6.4.2 Europe Biochemical Screening Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biochemical Screening Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biochemical Screening Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biochemical Screening Test Sales Value (2021-2032)
  16. 6.6.2 South America Biochemical Screening Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biochemical Screening Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biochemical Screening Test Sales Value Share by Country, 2025 VS 2032
7 Biochemical Screening Test Country-level Value Analysis
  1. 7.1 Global Biochemical Screening Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biochemical Screening Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biochemical Screening Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biochemical Screening Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biochemical Screening Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biochemical Screening Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biochemical Screening Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yourgene Health
  2. 8.1.1 Yourgene Health Company Information
  3. 8.1.2 Yourgene Health Business Overview
  4. 8.1.3 Yourgene Health Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yourgene Health Biochemical Screening Test Product Portfolio
  6. 8.1.5 Yourgene Health Recent Developments
  7. 8.2 Illumina Inc
  8. 8.2.1 Illumina Inc Company Information
  9. 8.2.2 Illumina Inc Business Overview
  10. 8.2.3 Illumina Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Illumina Inc Biochemical Screening Test Product Portfolio
  12. 8.2.5 Illumina Inc Recent Developments
  13. 8.3 Agilent Technologies Inc
  14. 8.3.1 Agilent Technologies Inc Company Information
  15. 8.3.2 Agilent Technologies Inc Business Overview
  16. 8.3.3 Agilent Technologies Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Technologies Inc Biochemical Screening Test Product Portfolio
  18. 8.3.5 Agilent Technologies Inc Recent Developments
  19. 8.4 Thermo Fisher Scientific Inc
  20. 8.4.1 Thermo Fisher Scientific Inc Company Information
  21. 8.4.2 Thermo Fisher Scientific Inc Business Overview
  22. 8.4.3 Thermo Fisher Scientific Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific Inc Biochemical Screening Test Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Inc Recent Developments
  25. 8.5 Hoffmann-La Roche Ltd
  26. 8.5.1 Hoffmann-La Roche Ltd Company Information
  27. 8.5.2 Hoffmann-La Roche Ltd Business Overview
  28. 8.5.3 Hoffmann-La Roche Ltd Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hoffmann-La Roche Ltd Biochemical Screening Test Product Portfolio
  30. 8.5.5 Hoffmann-La Roche Ltd Recent Developments
  31. 8.6 Laboratory Corporation of America Holdings
  32. 8.6.1 Laboratory Corporation of America Holdings Company Information
  33. 8.6.2 Laboratory Corporation of America Holdings Business Overview
  34. 8.6.3 Laboratory Corporation of America Holdings Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Laboratory Corporation of America Holdings Biochemical Screening Test Product Portfolio
  36. 8.6.5 Laboratory Corporation of America Holdings Recent Developments
  37. 8.7 GE Healthcare
  38. 8.7.1 GE Healthcare Company Information
  39. 8.7.2 GE Healthcare Business Overview
  40. 8.7.3 GE Healthcare Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GE Healthcare Biochemical Screening Test Product Portfolio
  42. 8.7.5 GE Healthcare Recent Developments
  43. 8.8 PerkinElmer Inc
  44. 8.8.1 PerkinElmer Inc Company Information
  45. 8.8.2 PerkinElmer Inc Business Overview
  46. 8.8.3 PerkinElmer Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PerkinElmer Inc Biochemical Screening Test Product Portfolio
  48. 8.8.5 PerkinElmer Inc Recent Developments
  49. 8.9 BGI
  50. 8.9.1 BGI Company Information
  51. 8.9.2 BGI Business Overview
  52. 8.9.3 BGI Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BGI Biochemical Screening Test Product Portfolio
  54. 8.9.5 BGI Recent Developments
  55. 8.10 Natera Inc
  56. 8.10.1 Natera Inc Company Information
  57. 8.10.2 Natera Inc Business Overview
  58. 8.10.3 Natera Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Natera Inc Biochemical Screening Test Product Portfolio
  60. 8.10.5 Natera Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst